hepatocellular carcinoma
The copper chelator trientine has an antiangiogenic effect against hepatocellular carcinoma, possibly through inhibition of interleukin-8 production.
The copper chelator trientine has an antiangiogenic effect against <span class="disease" id="12432545-0-67-91">hepatocellular carcinoma</span>, possibly through inhibition of <span class="gene" id="12432545-0-124-137">interleukin-8</span> production.